Tag Archives: USFDA

Dr REDDY’s gets USFDA nod to market medicine to treat tumour

PRINCETON (NEW JERSEY – US) HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Hyderabad headquartered pharmaceutical company Dr Reddy’s Laboratories Ltd said of having got USFDA (US Food & Drugs Administration) nod to market medicine to treat tumour for bone-marrow and cancer and has

STRIDE PHARMA gets USFDA nod to market pain-killer medicine

BANGALORE | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bangalore headquartered pharmaceuticals company Strides Pharma Sciences Ltd said its Singapore based step-down subsidiary company Strides Pharma Global Pte. Ltd., Singapore of having got USFDA (US Food and Drugs Administration) approval to market pain-killer medicine –

ALEOR DERMA gets USFDA nod to market medicine to treat knee pain

VADODARA (BARODA) | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing company Alembic Pharmaceuticals Ltd said of its joint-venture company Aleor Dermaceuticals having got USFDA nod to market medicine to treat knee pain. In a press-release as submitted by the company to the

ALEMBIC PHARMA gets USFDA nod to sell medicine to cure Prostate Enlargement

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having got nod to market medicines to treat prostate enlargement disease. In a press-release as submitted by the company to the Indian Bourses, titled – “Alembic Pharmaceuticals receives

INDOCO REMEDIES’ CRO – AnaCipher receives EIR from USFDA

HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory updates submitted to the Indian Stock Exchanges, Hyderabad headquartered Indoco Remedies Ltd’s Clinical Research Organization (CRO) has been inspected by USFDA (US Food and Drugs Administration) and cleared being granted Establishment Inspection Report (EIR). In a press-release as submitted by the company to the

GLENMARK PHARMA gets USFDA nod to market medicine to treat obesity

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Glenmark Pharmaceuticals Ltd said of having received USFDA (US Food and Drugs Administration) nod to market medicine to treat obesity and overweight related disorders. In a company press-release as submitted to the Indian Bourses, titled – “Glenmark

USFDA inspects INDOCO REMEDIES’ Goan plants gives EIR

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Indoco Remedies Ltd said of its Goan plants inspected and having received Establishment Inspection Report (EIR). In a press-release submitted to the Indian Bourses, titled – “Indoco receives EIR for its manufacturing facilities in Goa (Plant II

ALEMBIC PHARMA gets USFDA nod to sell tablets to treat iron levels in blood

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Vaoddara headquartered pharmaceutical products manufacturing company Alembic Pharmaceuticals Ltd said of having got nod to market medicine to treat iron levels in blood, especially to treat chronic iron overload due to blood transfusions in patients of

CADILA HEALTH (ZYDUS) gets USFDA nod to market medicine for cardiac cure & skin treatment

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel lead Zydus Cadila Group) said of having got nod from USFDA (US Food & Drugs Administration) to market medicines to cure cardiac problems and skin-treatment. In a press-release as submitted by

NATCO Pharma’s Vishakhapatnam Formulation facility kicks-off

HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Hyderabad headquartered NATCO Pharma Ltd said of having commenced commercial manufacturing operations at company’s Vishakhapatnam formulation facility. In a press-release as submitted by the company to the Indian Bourses, titled – “Commercial Manufacturing Operations begin in NATCO’s

GLENMARK PHARMA gets USFDA nod to market skin & pimple care treatment

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Glenmark Pharmaceuticals Ltd said of having got nod from USFDA (US Food & Drugs Administration) to market skin & pimple care treatment. The press-release as submitted by the company to the Indian Bourses – titled, “Glenmark

STRIDES PHARMA : USFDA announces Lab testing & analysis of Ranitidine Tablets

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered Pharma company Strides Pharma Science Ltd said of having its Rantidine Tablets tested by USFDA and the regulator has announced testing & analysis results of the company terming as NDMA (nitrosodimethylamine) levels with acceptable limits. The company

USFDA slams Form 483 to ALKEM LAB’s Daman plant, clears Baddi (HP) facility

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Exchanges, Mumbai headquartered pharma company Alkem Laboratories Ltd said of its Baddi (Himachal Pradesh) and Daman plants having inspected by USFDA (US Food and Drugs Administration) in month of August 2019, the regulators have given Establishment Inspection Report (EIR) to the

LUPIN gets USFDA nod to market medicine to cure Thyroid

BALTIMORE | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press-release submitted to the Indian Stock Exchanges by Lupin Ltd, the company said of having got approval from USFDA (US Food & Drugs Administration) to market medicine to cure thyroid and thyroid related diseases. The company release as submitted to the Indian Bourses read that,

INDOCO REMIDIES gets USFDA nod to market medicine to treat acidity

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press release submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Indoco Remedies Ltd said of having got approval from USFDA (US Food & Drugs Administration) to market medicine, to treat acidity and gastric secretions. The press-release as submitted by the company to the Indian Bourses,

LUPIN gets USFDA nod to market drug to treat THYROID

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Lupin Ltd said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat Thyroid and related disorders. In a press-release as submitted by the company to the Indian Bourses, titled –

Do NOT follow this link or you will be banned from the site!